Long‐term (52‐week) efficacy and safety of dapagliflozin as an adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the
DEPICT
‐2 study
Keyword(s):
Keyword(s):
2017 ◽
Vol 19
(2)
◽
pp. 109-114
◽
Keyword(s):
2020 ◽
Vol 22
(9)
◽
pp. 1516-1526
◽
Keyword(s):
Keyword(s):
Keyword(s):